Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Genital Neoplasms, Male × niraparib × 1 year × Clear all

Sponsor

Conditions

Ovarian Neoplasms 23 Prostatic Neoplasms 10 Breast Neoplasms 10 Fallopian Tube Neoplasms 9 Neoplasms 7 Neoplasm Metastasis 7 Pancreatic Neoplasms 6 Endometrial Neoplasms 5 Glioblastoma 4 Triple Negative Breast Neoplasms 3 Lung Neoplasms 3 Glioma 3 Small Cell Lung Carcinoma 2 Recurrence 2 Prostatic Neoplasms, Castration-Resistant 2 Head and Neck Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Advanced Solid Tumor 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Unilateral Breast Neoplasms 1 Sarcoma 1 SCLC,Extensive Stage 1 Rectal Neoplasms 1 Prostate Carcinoma Metastatic to the Bone 1 Prostate Adenocarcinoma 1

Interventions

olaparib 1 gallium 68 PSMA-11 1 Pluvicto 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡